Direct-acting Anticoagulants in Chronic Coronary Syndromes
Direct-acting oral anticoagulants (DOACs) are easier to use, safer than and as effective as vitamin K antagonists (VKA) in the treatment of non-valvular AF (NVAF). Because of their favourable safety profile and easier use than VKAs, DOACs as anti-thrombotic therapy may have a role in the management...
Saved in:
Main Authors: | , |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/02fb7af57d97422ebc19c8dc1b480c2b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|